Pro-Dex (co) Overview
Pro-Dex (co) (PDEX) has a P/E ratio of 17.75, below the Healthcare sector average of 26.85.
Get informed when a big investor buys or sells
+ Follow17.75
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for PDEX is 17.75. That is below the Healthcare sector average of 26.85. Investors often review this figure alongside Pro-Dex (co)'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, PDEX currently prints 17.75 for P/E ratio, while the sector average sits near 26.85. That is roughly 33.9% below the sector mean. Large gaps often invite a closer look at Pro-Dex (co)'s growth, margins, and balance sheet.
A P/E ratio of 17.75 for Pro-Dex (co) is not 'good' or 'bad' on its own. Compare it with the peer average (26.85) and with PDEX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting PDEX's P/E ratio (17.75), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Pro-Dex (co)'s P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
